Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes MR, Chabaud S, Brihoum M, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Reiter RE, Eggener S, Brisbane W, Roy S, Zaorsky NG, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Mohamad O, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE. Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet. 2026 Feb 26:S0140-6736(26)00137-6. doi: 10.1016/S0140-6736(26)00137-6. Epub ahead of print. PMID: 41765025.


Related Posts